Effects of Sea Buckthorn Whole Fruit Puree on Plasma Glucose in People with Impaired Glucose Regulation: A Randomized Crossover Intervention Study

Zhongxia Ren,Huiting Gong,Ai Zhao,Peiyu Wang,Yumei Zhang
DOI: https://doi.org/10.1093/cdn/nzaa061_107
2020-01-01
Current Developments in Nutrition
Abstract:To explore the effect of sea buckthorn whole fruit puree (SBFP) on fasting plasma glucose (FPG) and postprandial plasma glucose response in people with impaired glucose regulation (IGR). A two-stage randomized crossover-control and double-blind intervention study was conducted. The SBFP was produced by the Hippophae rhamnoides L. subsp. Sinensis. Forty-five subjects aged 50–70 years old with IGR (6.1 mmol/L ≤ FPG <7.0 mmol/L and/or 5.6% ≤Hemoglobin A1c ≤ 6.5%) were included and randomly divided into two groups (22 subjects in group AB and 23 in BA, respectively). Subject in group AB consumed SBFP (90 mL/d), washed out and then consumed placebo (90 mL/d) for 35, 28, 35 days, respectively, while the sequence of group BA was reversed. Fasting and postprandial (30, 60 and 120 min after a standard meal) blood samples were collected at the start and the end of every intervention period, and the concentration of plasma glucose was detected by the glucose oxidase method. Using a trapezoidal area formula, the area under the curve of 2 hours postprandial plasma glucose (PG-AUC) was calculated. The effect of the intervention was evaluated by general linear model. Six subjects in group AB and One in BA voluntarily withdrew before the first period of intervention and other 38 subjects completed the whole intervention. Consumption of 90 mL SBFP for 35 days (n = 38) resulted in a reduction of 0.13 ± 0.56 mmol/L (P = 0.173) on FPG in subjects with IGR, but the placebo intervention (n = 38) resulted in an increase of 0.12 ± 0.47 mmol/L (P = 0.122), and the difference in intervention was statistically significant (P = 0.045). The PG-AUC increased by 0.22 ± 1.02 h mmol/L (P = 0.184) and 0.07 ± 1.38 h mmol/L (P = 0.755), respectively, while no significant difference was observed (P = 0.871). During the wash-out period, the FPG changed with a decrease of 0.28 ± 0.61 mmol/L in the SBFP group (group AB, P = 0.080) but an increase of 0.16 ± 0.82 mmol/L in the placebo group (group BA, P = 0.373), and the effect was significantly different (P = 0.043). No significant difference was found for PG-AUC. Daily consumption of 90 mL SBFP for 35 days played a positive role in reducing the FPG in people with IGR, and it might still be effective within 28 days after discontinued use. The National Natural Science Foundation of China (No. 81773420).
What problem does this paper attempt to address?